Skip to Content
Morningstar

Alcon Inc ALC

Morningstar Rating
Unlock
Stock XSWX Rating as of
CHF 83.00 +1.02 (1.24%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Price vs Fair Value

View History
ALC is trading within a range we consider fairly valued.
Price
CHF 83.00
Fair Value
CHF 92.00
Uncertainty
Medium
1-Star Price
CHF 56.80
5-Star Price
CHF 41.50
Economic Moat
Thxjr
Capital Allocation
Fxcrskmh

Bulls Say, Bears Say

Bulls

Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products.

Bears

A failure to help doctors transition from Centurion to a new phacoemulsification machine (upon launch in the next two years) could leave some customers unsatisfied and moving to a different manufacturer.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ALC is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
CHF 81.98
Day Range
CHF 81.20–83.16
52-Week Range
CHF 61.28–83.34
Bid/Ask
CHF 0.00 / CHF 0.00
Market Cap
CHF 40.94 Bil
Volume/Avg
645,988 / 859,682

Key Statistics

Price/Earnings (Normalized)
30.18
Price/Sales
4.87
Dividend Yield (Trailing)
0.29%
Dividend Yield (Forward)
0.29%
Total Yield
0.29%

Company Profile

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
25,315
Website
https://www.alcon.com

Competitors

Valuation

View More
Metric
ALC
AFX
COO
Price/Earnings (Normalized)
 30.1820.8127.37
Price/Book Value
 2.182.582.38
Price/Sales
 4.872.624.99
Price/Cash Flow
 23.5016.6420.27
Price/Earnings
ALC
AFX
COO

Financial Strength

Metric
ALC
AFX
COO
Quick Ratio
 1.312.340.84
Current Ratio
 2.513.511.95
Interest Coverage
 5.8619.185.25
Quick Ratio
ALC
AFX
COO

Profitability

Metric
ALC
AFX
COO
Return on Assets (Normalized)
 4.73%9.06%2.88%
Return on Equity (Normalized)
 6.76%12.67%4.48%
Return on Invested Capital (Normalized)
 5.92%11.05%4.10%
Return on Assets
ALC
AFX
COO
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Instruments & Supplies Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
PfspzzyqcqCfr$156.8 Bil
 Becton Dickinson & Co
BDX
WsywdgxjLymzhk$68.6 Bil
 Alcon Inc
ALC
KtwbbpnMgpbxfw$46.5 Bil
 Coloplast A/S ADR
CLPBY
XgdydxnjrXlqqm$29.1 Bil
 ResMed Inc
RMD
KlzczrywWhzrhs$28.9 Bil
 West Pharmaceutical Services Inc
WST
DxlnbdmlzKfvg$20.7 Bil
 The Cooper Companies Inc
COO
VkwhqmjmYrkxnyj$18.6 Bil
 Hologic Inc
HOLX
MkbqdxsFgrzk$18.4 Bil
 Baxter International Inc
BAX
WggtphgxCzczst$18.1 Bil
 Teleflex Inc
TFX
PvllDmhv$10.4 Bil

Sponsor Center